ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,159
Screening encounters
2,338
Diagnostic referrals
452
Outstanding pathways
192

Screening pathway

  1. Screening2,338Encounters
  2. Positive finding783Documented findings
  3. Referral452Diagnostic referrals
  4. Follow-up500Diagnostic visits
  5. Outcome260Resolved pathways

Stage totals use different units. Pending pathways: 192. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0460 · EXP-0460Synthetic · Site D

Full participant history through 2026-01-16, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-12-07
  4. · Diagnostic referral · EXP-0460-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Contact difficulty
  8. · Contact attempt · Unsuccessful
  9. · Contact attempt · Unsuccessful
  10. · Navigation intervention · Coordination support
  11. · Diagnostic visit · Missed
  12. · Diagnostic booking · Rebooking
  13. · Diagnostic visit · Attended
  14. · Diagnosis · Colposcopy · Biopsy collected
  15. · Diagnosis · Histopathology · No high-grade lesion identified
  16. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-09-06
  17. · Follow-up disposition · Resolved · EXP-0460-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

2159 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0872 · Expanded synthetic participant 0872Site E — Resource-Constrained Navigation Programme
EXP-0874 · Expanded synthetic participant 0874Site E — Resource-Constrained Navigation Programme
EXP-0875 · Expanded synthetic participant 0875Site C — Rural Outreach Programme
EXP-0876 · Expanded synthetic participant 0876Site B — Peri-Urban Access Programme
EXP-0878 · Expanded synthetic participant 0878Site C — Rural Outreach Programme
EXP-0881 · Expanded synthetic participant 0881Site B — Peri-Urban Access Programme
EXP-0883 · Expanded synthetic participant 0883Site C — Rural Outreach Programme
EXP-0884 · Expanded synthetic participant 0884Site D — Community Engagement Programme
EXP-0886 · Expanded synthetic participant 0886Site A — Urban Referral Hub
EXP-0893 · Expanded synthetic participant 0893Site A — Urban Referral Hub
EXP-0894 · Expanded synthetic participant 0894Site A — Urban Referral Hub
EXP-0896 · Expanded synthetic participant 0896Site A — Urban Referral Hub
EXP-0898 · Expanded synthetic participant 0898Site A — Urban Referral Hub
EXP-0899 · Expanded synthetic participant 0899Site C — Rural Outreach Programme
EXP-0901 · Expanded synthetic participant 0901Site A — Urban Referral Hub
EXP-0904 · Expanded synthetic participant 0904Site B — Peri-Urban Access Programme
EXP-0906 · Expanded synthetic participant 0906Site B — Peri-Urban Access Programme
EXP-0908 · Expanded synthetic participant 0908Site D — Community Engagement Programme
EXP-0910 · Expanded synthetic participant 0910Site C — Rural Outreach Programme
EXP-0912 · Expanded synthetic participant 0912Site D — Community Engagement Programme
EXP-0914 · Expanded synthetic participant 0914Site A — Urban Referral Hub
EXP-0915 · Expanded synthetic participant 0915Site B — Peri-Urban Access Programme
EXP-0916 · Expanded synthetic participant 0916Site B — Peri-Urban Access Programme
EXP-0917 · Expanded synthetic participant 0917Site D — Community Engagement Programme
EXP-0918 · Expanded synthetic participant 0918Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
985
HPV DNA
1007
Cytology
346

Navigation activity

Barrier documented
380
Contact attempt
663
Navigation intervention
158
Diagnostic booking
554
Diagnostic visit
500

Documented barriers

Contact difficulty
118
Transport difficulty
129
Appointment coordination
133

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.